H. Goike

875 total citations
10 papers, 690 citations indexed

About

H. Goike is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Genetics. According to data from OpenAlex, H. Goike has authored 10 papers receiving a total of 690 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 3 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in H. Goike's work include Glioma Diagnosis and Treatment (3 papers), Cancer Research and Treatments (2 papers) and Cancer-related Molecular Pathways (2 papers). H. Goike is often cited by papers focused on Glioma Diagnosis and Treatment (3 papers), Cancer Research and Treatments (2 papers) and Cancer-related Molecular Pathways (2 papers). H. Goike collaborates with scholars based in Sweden, United Kingdom and Belgium. H. Goike's co-authors include V. Peter Collins, Koichi Ichimura, Esther Schmidt, Gunnar Johansson, Georgios Stratelis, L. Jörgensen, Kjell Larsson, Björn Ställberg, Christer Janson and Daniel Brattström and has published in prestigious journals such as BMJ, British Journal of Cancer and Urology.

In The Last Decade

H. Goike

10 papers receiving 678 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Goike Sweden 8 341 281 204 189 150 10 690
Shobha Castelino‐Prabhu United States 10 486 1.4× 153 0.5× 232 1.1× 105 0.6× 90 0.6× 15 796
Elena Lualdi Italy 7 355 1.0× 128 0.5× 141 0.7× 147 0.8× 77 0.5× 9 568
Koji Oka Japan 9 310 0.9× 351 1.2× 227 1.1× 138 0.7× 195 1.3× 23 727
Anna Maria Cianciulli Italy 16 263 0.8× 212 0.8× 285 1.4× 198 1.0× 155 1.0× 22 721
Inés González‐Herrero Spain 12 493 1.4× 106 0.4× 340 1.7× 60 0.3× 195 1.3× 24 762
Matilda Rehn Sweden 12 382 1.1× 112 0.4× 179 0.9× 81 0.4× 292 1.9× 24 862
Nina Ilić Australia 12 378 1.1× 270 1.0× 81 0.4× 204 1.1× 110 0.7× 14 718
Silvana Di Giandomenico United States 10 537 1.6× 87 0.3× 263 1.3× 115 0.6× 184 1.2× 16 865
Kevin C. De Braganca United States 13 272 0.8× 267 1.0× 196 1.0× 152 0.8× 61 0.4× 34 613
J T Robertson United States 5 395 1.2× 138 0.5× 165 0.8× 64 0.3× 221 1.5× 6 586

Countries citing papers authored by H. Goike

Since Specialization
Citations

This map shows the geographic impact of H. Goike's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Goike with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Goike more than expected).

Fields of papers citing papers by H. Goike

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Goike. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Goike. The network helps show where H. Goike may publish in the future.

Co-authorship network of co-authors of H. Goike

This figure shows the co-authorship network connecting the top 25 collaborators of H. Goike. A scholar is included among the top collaborators of H. Goike based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Goike. H. Goike is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
3.
Poppel, Hendrik Van, et al.. (2008). POD-4.01: Role of TPS, TPA and PSA in Treatment Monitoring of Prostate Carcinoma. Urology. 72(5). S40–S40. 1 indexed citations
4.
Eriksson, Peter, Daniel Brattström, Patrik Hesselius, et al.. (2006). Role of circulating cytokeratin fragments and angiogenic factors in NSCLC patients stage IIIa-IIIb receiving curatively intended treatment.. PubMed. 53(4). 285–90. 8 indexed citations
5.
Brattström, Daniel, Gunnar Wagenius, Per Sandström, et al.. (2005). Newly developed assay measuring cytokeratins 8, 18 and 19 in serum is correlated to survival and tumor volume in patients with esophageal carcinoma. Diseases of the Esophagus. 18(5). 298–303. 11 indexed citations
6.
Goike, H., et al.. (2000). Cryopreservation of viable human glioblastoma xenografts. Neuropathology and Applied Neurobiology. 26(2). 172–176. 7 indexed citations
7.
Ichimura, Koichi, et al.. (2000). Deregulation of the p14ARF/MDM2/p53 pathway is a prerequisite for human astrocytic gliomas with G1-S transition control gene abnormalities.. PubMed. 60(2). 417–24. 222 indexed citations
8.
Gedda, Lars, H. Goike, Li Liu, et al.. (1998). Uptake of a boronated epidermal growth factor-dextran conjugate in CHO xenografts with and without human EGF-receptor expression.. PubMed. 13(4). 279–89. 15 indexed citations
9.
Ichimura, Koichi, et al.. (1997). Infrequent methylation of CDKN2A(MTS1/p16) and rare mutation of both CDKN2A and CDKN2B(MTS2/p15) in primary astrocytic tumours. British Journal of Cancer. 75(1). 2–8. 64 indexed citations
10.
Ichimura, Koichi, Esther Schmidt, H. Goike, & V. Peter Collins. (1996). Human glioblastomas with no alterations of the CDKN2A (p16INK4A, MTS1) and CDK4 genes have frequent mutations of the retinoblastoma gene.. PubMed. 13(5). 1065–72. 214 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026